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Human H-chain ferritins hearing sequence changes in the 3-fold channels have been expressed in E. co/i to investigate 
the role of these channels in iron-storage processes. The proteins assemble into shells resembling those of native ferritins. 
Iron uptake measurements indicate that residues in the 3-fold channels are involved neither in initial Fe(H)-oxidation 
nor in iron-core nucleation. 
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1. INTRODUCTION 
The iron-storage protein, ferritin, is a 24-mer of 
two types of subunit, H and L, coassembled into 
a hollow shell that provides a cavity in which iron 
is deposited as the mineral ferrihydrite [ 11. In vitro 
ferritin reconstitution can be achieved by the addi- 
tion of Fe(I1) to apoferritin in the presence of an 
oxidant [2,3]. Apoferritin facilitates ferrihydrite 
formation by providing sites at which Fe(I1) oxida- 
tion is accelerated [2-51 and those at which the 
iron-core mineral is nucleated [3] which may or 
may not be the same. It has recently been suggested 
that there is a ‘ferroxidase’ site on the outside of 
the molecule, since Fe(II1) can be transferred to 
added apotransferrin [5]. Fe(II1) (or Fe(I1)) must 
be able to traverse the protein shell to reach the 
storage cavity. 
We have previously observed, by UV difference 
spectroscopy, the formation of an initial Fe(III)- 
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apoferritin complex, when 4-8 Fe(I1) atoms are 
added to apoferritin at pH 6.5 [6]. The spectrum 
changes with time due, we believe, to the migration 
of Fe(II1) atoms from isolated sites to give nuclea- 
tion clusters. Comparable changes are seen by 
EPR [7] and Mossbauer [8] spectroscopy. The 
three-dimensional structures of horse spleen 
apoferritin [l] and of recombinant L-chain and H- 
chain homopolymers as well as of native rat liver 
apoferritin (Lawson, D.M., Artymiuk, P.J. and 
Harrison, P.M., unpublished work) show the 
presence of eight channels at 3-fold symmetry 
axes. We investigate here the hypotheses that these 
channels provide the route by which iron traverses 
the shell and that they contain the initial Fe(II)- 
oxidation site [6,9,10]. Our approach is to make 
mutant proteins by over-expression in Escherichiu 
coli of human H-chain genes containing ap- 
propriate codon changes. We then examine the 
formation of the initial Fe(III)-apoferritin complex 
at a pH (5.9) at which the ferrihydrite core forma- 
tion is inhibited, and separately, the rate of core 
formation when 500 Fe(I1) atoms/apoferritin 
molecule are added at pH 6.8. The 3-fold channels 
consist of an inner narrow region surrounded by 
three highly conserved aspartates (sequence 
no. 13 1) and three glutamates (no. 134) that are 
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known to bind metal ions [l 11, and an outer, wider 
region in which several amino acid changes are 
found when H- and L-chain sequences are com- 
pared [12]. To investigate the two regions we have 
made the following changes: Asp13 1 -His; 
Glu134-His; Asp131,Glu134*His; Asp 
131-Ala; Glu134-Ala; Asp131,Glu134- 
Ala; Ala-Thr-Asp-Lys-Asn( 121- 125)-Gly-Ser- 
Ala-Gln-Thr. All of these mutations have been 
superimposed on a separate single change, Lys- 
86-+Gln, introduced to induce crystallization by 
formation of intermolecular metal bridges as in 
horse spleen apoferritin [ 111. Apoferritin bearing 
the single Lys86-Gln change has been used as 
control in studies of iron uptake. For convenience, 
when describing the mutants, the control will be 
described as Lys86-Gin and the others imply as 
Asp131-His etc. and H(121-125)-L. 
dialysed against BBS and reduction was carried out in an 8MC 
ultrafiltration cell (Amicon, High Wycombe, Bucks, England) 
equipped with a YMlOO Diaflo membrane. The reducing solu- 
tion of 50 mM thioglycollic acid in 50 mhd Mes buffer, pH 6.0, 
containing 0.15 M NaCl. was placed in the reservoir with the 
protein (usually 0.5-0.9 ml of a 10-U) mg/ml solution) in the 
sample compartment. Fe(H) in the filtrate was measured as its 
2,2’-bipyridine complex. 
2.3. Monitoring of purity and assembly 
2. METHODS 
Protein was assayed with the Bio-Rad micro-assay kit with 
BSA as standard. Purity was checked and subunits analysed by 
electrophoresis in 12.5% polyacrylamide gels containing 1% 
SDS, the sample being first boiled for 10 min in 62.5 mM Tris 
containing 10% glycerol, 5% mercaptoethanol, 2.3% SDS. 
Subunit folding and assembly was monitored by electrophoresis 
in 6% polyacrylamide gels and by immunoassay. Microtest 
plates were coated overnight with the test ferritins (1 fig/ml) in 
0.05 M sodium bicarbonate buffer, pH 9.5. Immunoassays 
were carried out with polyclonal antisera prepared in our 
laboratory [15] and with anti-human H-chain monoclonal an- 
tibody 2A4 (kindly provided by P. Arosio), serially diluted over 
a suitable range. Bound IgG was detected with either anti-rabbit 
or anti-mouse IgG coupled to peroxidase using 3,3 ’ ,5,5 ’ -tetra- 
methyl-benzidine as substrate [16]. 
2.1. Expression and isolation of recombinant H-chain ferritins 
To express the H-chain of ferritin we made use of plasmid 
p2HFt-91 that directs the synthesis of large quantities of ferritin 
mRNA under the control of the APL promoter [13]. This 
plasmid is a derivative of p2HFt [ 141 in which the 3 ‘-end of the 
ferritin gene has been fused, by site directed mutagenesis, to the 
gene encoding the cu-peptide of &galactosidase. The two genes, 
however, are separated by an amber codon and, in a su- strain, 
translation stops at the carboxy-terminus of ferritin. The 
bacterial host used for ferritin production is GC382d[lac- 
pro]/F’ [la@ /acZAM15proAB+]~p”/pC1857 where pCI857 is 
a plasmid conferring kanamycin resistance and carrying the 
temperature-sensitive allele of the h repressor. Mutants have 
been constructed by standard site directed mutagenesis 
techniques. 
2.4. Iron uptake 
Formation of the initial Fe(lII)-apoferritin complex was 
measured after addition of 4 Fe(H) atoms/molecule to apofer- 
ritin (1 mg/ml) in 0.05 M Mes buffer, pH 5.9, by UV difference 
spectroscopy in a Cary 219 double beam spectrophotometer [6]. 
Spectra in the wavelength range 250-400 run due to the com- 
plex were measured repeatedly until they were fully developed. 
Relative rates were obtained by measuring the absorbance at 
Ferritin over-expression was achieved by thermo-inactivation 
of the h repressor. A 60 1 fermenter was inoculated with 3 1 of 
an overnight saturated culture of CC382 containing p2HFt-91 
or its derivatives. The temperature was maintained at 30°C till 
the culture reached an absorbance of 0.4 at 600 nm. At this 
point the temperature was raised to 42°C and, after 3 h of fur- 
ther incubation at this temperature, the cells were collected by 
centrifugation in a continuous flow rotor. 
Cells were suspended in 0.02 M sodium borate buffered 
saline, pH 7.2, containing 0.02%, w/v, NaN3 (BBS), 4 ml/g 
cell paste, and sonicated for 5 x 1 min. The homogenate was 
heated to 75°C for 5 min and centrifuged. The supernatant was 
applied to a Sepharose 6B column (5 x 70 cm) and eluted with 
BBS. The purest fractions (monitored by gel electrophoresis) 
were pooled and precipitated with ammonium sulphate (37%, 
w/v). 
2.2. Iron removal 
Fig.1. Electrophoresis in 6% polyacrylamide gel of human 
ferritins stained with Coomassie blue. Tracks l-4 are mutant 
H-chain ferritins, 5 and 6 are native human brain and human 
liver ferritins, respectively. Mutants are: 1, H(121-125)-L; 
2, Asp131,Glu134--rAla; 3, Asp131,Glul34-+His; 4, 
For iron removal, ammonium sulphate precipitates were Lys86-Gin. 
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Fig.2. Electrophoresis in an SDS-12.5% polyacrylamide gel of 
human ferritin subunits stained with Coomassie blue. Tracks 1 
and 2 are native human brain and liver ferritins, respectively. 
The lower bands in 1 and 2 are human L-chains. Mutant H- 
chains in tracks 3-10 are: 3, Lys86--*Gln; 4, Aspl31-+His; 
5, Glu134+His; 6, Asp131,Glu134--*His; 7, H(121- 
125)-L; 8, Glu134-+Ala; 9, Aspl31bAla; 10, Asp131, 
Glu134-+Ala. 
310 nm reached at 10 s and expressing this as a percent of the 
maximum absorbance. Formation of the iron core was followed 
by adding 500 Fe(B) atoms/molecule to apoferritin (50 pg/ml) 
in 0.05 M Mops buffer, pH 6.8, and monitoring the increase in 
absorbance at 310 nm. Iron was added as a (NI-I&Fe(SO& 
solution in deoxygenated water for both types of experiment. 
3. RESULTS AND DISCUSSION 
On electrophoresis in 6% polyacrylamide gels 
(fig.l), all the recombinants showed bands at 
similar positions to those of native ferritins. The 
H-chain homopolymers migrate somewhat faster 
than ferritins from human brain (66% H-subunit) 
or liver (20% H-subunit). Although H-chains are 
slightly larger than L-chains [17], they are more 
acidic. The greater basicity of mutant 
Asp13 1 ,Glu134-His may explain why it is 
slightly retarded compared with the other recom- 
binants (fig.1). Minor, more slowly migrating, 
bands like those attributed to molecular oligomers 
in native ferritins [18] are also visible on the gels. 
Fig.2 shows that each of the mutants gave a single 
Fig.3. Immunoassay of human ferritins. Two human H-chain recombinant ferritins, Lys86-+Gln (0) and H(121-125)-L (0) are 
compared with native human brain ferritin (A) and liver ferritin (A). (a) Monoclonal 2A4 specific to the H-subunit; (b) antiserum 
to human brain ferritin; (c) antiserum to human spleen ferritin; (d) antiserum to the 3-fold channel residues 120-129; (e) antiserum 
to the 4-fold channel, residues 155-166. 
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H-subunit band, unlike the tissue ferritins which 
gave both H- and L-subunit bands. Minor low 
molecular mass bands, similar to those in native 
ferritins, probably result from proteolytic diges- 
tion of a small fraction of molecules within intact 
molecules. 
Fig.3 shows the results of ELBA for two recom- 
binants, Lys86-Gln and H(121-125)-L, and 
for native human brain and liver ferritins. The 
other mutants gave values close to those for 
Lys86-Gin. It can be seen that monoclonal2A4 
recognises brain ferritin and both recombinants 
(and this indicates that the epitopic centre it 
recognises is not at the outside exit of the 3-fold 
channels), but not liver ferritin (fig.3a). Anti-brain 
ferritin polyclonal (fig.fb) recognises the recom- 
binants, whereas anti-spleen ferritin (fig.3c) does 
not, except for weak recognition of H(121- 
125)-L. The latter is also weakly reactive to 
polyclonal antisera directed to the 3-fold channel 
L-subunit peptides (fig.3d), although not to that 
directed to the 4-fold channel L-chain peptides 
(fig.3e). Neither of these antisera react with 
Lys86-Gln although they recognise both spleen 
and brain ferritins. 
The above results indicate that the recombinants 
had assembled into molecules resembling native 
ferritins. This is borne out by the fact that several 
of the mutants have been crystallized and three of 
them, Lys86-Gln, Glu134-Ala and Asp- 
131 -His have been found to give crystals that 
are isomorphous with those of rat liver ferritin and 
that diffract to high angles (Lawson, D.M., Ar- 
tymiuk, P.J., Yewdall, S.J., Smith, J.M.A. and 
Harrison, P.M., unpublished results). 
Initial Fe(III)-apoferritin UV difference spectra 
developed after adding Fe(I1) to the various recom- 
binants all show an absorbance shoulder with a 
maximum at 290-295 nm (fig.4), very similar to 
the ‘initial spectrum’ seen previously with horse 
spleen [6] and rat liver [19] apoferritin. Except for 
Asp131, Glu134-His which gave relatively low 
absorbance, the peak heights were approximately 
the same for all the mutants. From this we must 
conclude that the ligands of the Fe(III)-apoferritin 
complex are not Aspl31, Glu134 or residues Ala- 
Thr-Asp-Lys-Asn( 12 1 - 125) respectively in the nar- 
row part or the wider mouth of the 3-fold chan- 
nels. This conclusion is supported by work with 
recombinant rat L-chain ferritin [20], which has all 
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Fig.4. Initial UV difference spectra of 4 Fe(III)-apoferritin 
complexes of human H-chain ferritins in 0.05 M Mops buffer, 
pH 5.9. (a) Lys86---rGln (---), Aspl31--*His (-), 
Asp131,Glu134_His (-----); (b) Lys86---*Gln (---), 
Glu134bAla (-), Asp131,Glu134--+Ala (-----). 
of these residues, but which gives no initial Fe(III)- 
apoferritin complex. 
The absence of the initial Fe(II)-oxidation site 
from the 3-fold channels does not rule out the use 
of these channels as the route or a route, by which 
iron traverses the shell. In principle it may do so 
either as Fe(I1) or Fe(III), implying respectively ox- 
idation on the inside or outside of the molecule. 
Table 1 gives the relative initial rates of formation 
of the iron core for the various mutants. Although 
all of them reached approximately the same final 
absorbance, some diminution of rate can be seen 
especially for Asp 13 1 ,Glu 134-His and Glu- 
134-His, but in no case was there complete in- 
hibition. The results could mean that iron does in- 
deed enter the molecule by the 3-fold channels, but 
if so, a specific mechanism involving ligand ex- 
change by metal-binding carboxyls is evidently not 
required. Previous studies implicating the 3-fold 
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